Samina Vaziralli

• Samina Vaziralli joined Cipla in 2011 with no prior experience in the pharmaceutical industry.
• Upon her arrival, Cipla was facing challenges, including the passing of Aman Lulla, the joint managing director, and a slowdown in growth.
• Despite her lack of pharmaceutical experience, Vaziralli, an alumna of the London School of Economics and former investment banker at Goldman Sachs, spearheaded the revitalization of the 83-year-old company.
• She focused on modernizing the company while preserving its longstanding commitment to producing affordable AIDS drugs.
• Vaziralli played a crucial role in strengthening Cipla's management team, which had faced significant turnover in recent years.
• Under the leadership of Umang Vohra, Cipla's managing director and global CEO, the company shifted its focus to priority markets and exited certain countries.
• Cipla experienced a notable 40% increase in profit after tax in FY18.
• Recent achievements include obtaining approval for new drugs in the U.S. and forming a marketing partnership with MSN Labs, based in Hyderabad, to market the latter's oncology drug in the U.S.

Female

Married